The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
复制标题
DOI：
10.1016/j.jclinepi.2021.03.001
复制
发表时间：
2021-05-17
影响因子：
7.2
通讯作者：
Moher, David
中科院分区：
文献类型：
--
作者：
Page, Matthew J.;McKenzie, Joanne E.;Moher, David
系统性综述和荟萃分析的首选报告项目（PRISMA）声明于2009年发布，旨在帮助系统性综述者透明地报告为什么进行综述，作者做了什么，以及他们发现了什么。在过去的十年中，系统性综述方法和术语的进步需要更新指南。PRISMA 2020声明取代了2009年的声明，并包括新的报告指南，反映了识别，选择，评估和综合研究方法的进步。项目的结构和列报方式已作修改，以便于执行。在本文中，我们介绍了PRISMA 2020 27项清单，一个扩展的清单，详细介绍了每个项目的报告建议，PRISMA 2020摘要清单，以及原始和更新审查的修订流程图。(C)2021年，任作者。由Elsevier Inc.出版，Elsevier Ltd代表IJS Publishing Group Ltd，BMJ Publishing Group代表British Medical Journal，PLOS; Springer Nature代表BioMed Central。
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. (C) 2021 The Author(s). Published by Elsevier Inc., Elsevier Ltd on behalf of IJS Publishing Group Ltd, BMJ Publishing Group on behalf of the British Medical Journal, PLOS; and Springer Nature on behalf of BioMed Central.